Document Detail


Mitochondrial/lysosomal toxic cross-talk plays a key role in cisplatin nephrotoxicity.
MedLine Citation:
PMID:  20809784     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cisplatin is widely used chemotherapeutic agent for the treatment of several human malignancies. Dose-related nephrotoxicity is the major adverse effect of cisplatin. The cellular and molecular mechanisms behind the cisplatin nephrotoxicity have not yet been completely understood. In this study, cytotoxic effect of cisplatin on renal proximal tubular (RPT) cells was evaluated. Our results showed that cytotoxic action of cisplatin on RPT cells is mediated by reactive oxygen species (ROS) formation, decline of mitochondrial membrane potential, increase in caspase-3 activity and lysosomal membrane leakiness before cell lysis ensued. All of the above mentioned cisplatin-induced oxidative stress cytotoxicity markers were significantly (p < 0.05) prevented by ROS scavengers, antioxidants, mitochondrial permeability transition (MPT) pore sealing agents, endocytosis inhibitors and adenosine triphosphate (ATP) generators. Our results also showed that CYP2E1 involves in cisplatin oxidative stress cytotoxicity mechanism and intracellular nitric oxide enhancement protects the RPT cells against the cisplatin-induced cytotoxicity. It seems that cisplatin nephrotoxicity is associated with mutual mitochondrial/lysosomal potentiation (cross-talk) of oxidative stress in RPT cells. This cross-talk finally results in release of lysosomal digestive proteases and phospholipases and mitochondrial MPT pore opening leading to cytochrome c release and activation of caspases cascade which signal apoptosis.
Authors:
Jalal Pourahmad; Mir-Jamal Hosseini; Mohammad Reza Eskandari; Seyed Mohammad Shekarabi; Bahram Daraei
Related Documents :
20861244 - Proteasome inhibition in vivo promotes survival in a lethal murine model of severe acut...
15716484 - Cisplatin-induced apoptosis is enhanced by hypoxia and by inhibition of mitochondria in...
20186654 - Inhibition of the ubiquitin-proteasome system by natural products for cancer therapy.
18752494 - Mesenchymal mechanisms in prostate organogenesis.
9566794 - Recombinant human il-16 inhibits hiv-1 replication and protects against activation-indu...
10099124 - Mucosal th1- versus th2-type responses for antibody- or cell-mediated immunity to simia...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Xenobiotica; the fate of foreign compounds in biological systems     Volume:  40     ISSN:  1366-5928     ISO Abbreviation:  Xenobiotica     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-10-12     Completed Date:  2011-01-27     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  1306665     Medline TA:  Xenobiotica     Country:  England    
Other Details:
Languages:  eng     Pagination:  763-71     Citation Subset:  IM    
Affiliation:
Faculty of Pharmacy, Shaheed Beheshti University of Medical Sciences, Tehran, Iran. j.pourahmadjaktaji@utoronto.ca
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antineoplastic Agents / toxicity*
Caspase 3 / metabolism
Cells, Cultured
Cisplatin / toxicity*
Kidney Diseases / chemically induced*,  metabolism
Kidney Tubules, Proximal / drug effects,  metabolism
Lysosomes / drug effects
Male
Membrane Potential, Mitochondrial / drug effects*
Oxidative Stress / drug effects
Rats
Rats, Sprague-Dawley
Reactive Oxygen Species / metabolism*
Receptor Cross-Talk / drug effects
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 0/Reactive Oxygen Species; 15663-27-1/Cisplatin; EC 3.4.22.-/Caspase 3

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Attribution theory and research.
Next Document:  Nogo receptor deletion and multimodal exercise improve distinct aspects of recovery in cervical spin...